Paoli J, Halldin C, Ericson M B, Wennberg A-M
Department of Dermatology, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden.
Clin Exp Dermatol. 2008 Aug;33(5):559-64. doi: 10.1111/j.1365-2230.2008.02755.x.
Photodynamic therapy (PDT) is a first-line therapeutic option for skin areas with multiple actinic keratoses (AKs). Its main drawback is the pain perceived during the irradiative phase, especially when treating field cancerization in the facial area. Effective pain-relieving strategies are needed.
To determine the effectiveness of peripheral nerve blocks in achieving pain relief during PDT for extensive facial AKs.
In total, 16 patients with symmetrically distributed facial AKs, mainly on the forehead, were enrolled in the study. Nerve blocks were applied unilaterally, and the nonanaesthetized side of the treatment area served as control. Maximum pain during PDT was evaluated using a visual analogue scale (VAS). Pain experienced after PDT was evaluated by telephone interview within 2 weeks of treatment. Cure rates were assessed at follow-up at least 4 weeks after treatment.
Pain was significantly reduced on the anaesthetized side (P < 10(-8)). The mean +/- SEM VAS score on the blocked side of the face was 1.3 +/- 0.3 compared with 7.5 +/- 0.5 on the nonanaesthetized side. Pain relief persisted 1-2 h after PDT. The nerve block was generally not experienced as painful (14/16 patients). Almost all patients (15/16 patients) would like to receive nerve blocks bilaterally if future PDT were needed. Excellent clinical results were observed in all patients after 4-20 weeks.
Nerve blocks provide efficient pain relief during PDT when treating patients with field cancerization of the forehead. Nerve blocks were not found to affect the clinical outcome of PDT, and were generally well tolerated by the patients.
光动力疗法(PDT)是治疗多处光化性角化病(AK)皮肤区域的一线治疗选择。其主要缺点是在照射阶段会有疼痛感,尤其是治疗面部的场癌化时。因此需要有效的止痛策略。
确定周围神经阻滞在大面积面部AK光动力治疗中实现疼痛缓解的有效性。
总共16例面部AK对称分布(主要在前额)的患者纳入本研究。神经阻滞单侧进行,治疗区域未麻醉的一侧作为对照。使用视觉模拟量表(VAS)评估光动力治疗期间的最大疼痛程度。在治疗后2周内通过电话访谈评估光动力治疗后的疼痛感受。在治疗后至少4周的随访中评估治愈率。
麻醉侧疼痛明显减轻(P < 10(-8))。面部阻滞侧的平均±标准误VAS评分为1.3±0.3,而未麻醉侧为7.5±0.5。光动力治疗后疼痛缓解持续1 - 2小时。神经阻滞一般不会引起疼痛(14/16例患者)。几乎所有患者(15/16例患者)表示如果未来需要进行光动力治疗,愿意接受双侧神经阻滞。4 - 20周后所有患者均观察到良好的临床效果。
在治疗前额场癌化患者时,神经阻滞在光动力治疗期间能有效缓解疼痛。未发现神经阻滞影响光动力治疗的临床结果,且患者对其耐受性普遍良好。